Chinese Clinical Guidelines for Continuous Glucose Monitoring (2018 Edition)

Diabetes Metab Res Rev. 2019 Sep;35(6):e3152. doi: 10.1002/dmrr.3152. Epub 2019 Apr 25.

Abstract

Blood glucose monitoring is an important part of diabetes management. Continuous glucose monitoring (CGM) technology has become an effective complement to conventional blood glucose monitoring methods and has been widely applied in clinical practice. The indications for its use, the accuracy of the generated data, the interpretation of the CGM results, and the application of the results must be standardized. In December 2009, the Chinese Diabetes Society (CDS) drafted and published the first Chinese Clinical Guideline for Continuous Glucose Monitoring (2009 edition), providing a basis for the standardization of CGM in clinical application. Based on the updates of international guidelines and the increasing evidence of domestic studies, it is necessary to revise the latest CGM guidelines in China so that the recent clinical evidence can be effectively translated into clinical benefit for diabetic patients. To this end, the CDS revised the Chinese Clinical Guideline for Continuous Glucose Monitoring (2012 Edition) based on the most recent evidence from international and domestic studies.

Keywords: continuous glucose monitoring; diabetes; guideline.

Publication types

  • Review

MeSH terms

  • Blood Glucose / analysis*
  • Blood Glucose Self-Monitoring / standards*
  • China / epidemiology
  • Diabetes Mellitus, Type 1 / blood*
  • Diabetes Mellitus, Type 1 / epidemiology
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / epidemiology
  • Guidelines as Topic*
  • Humans
  • Prognosis

Substances

  • Blood Glucose